Mythic Therapeutics

Drug Discovery · Waltham, MA · Founded 2017 · Out of Business

Developer of a biotechnology product platform designed to deliver chemotherapy directly to tumors through antibody-drug conjugates. Mythic Therapeutics is based in Waltham, MA and was founded in 2017. Its last known valuation is $293 million (Dec 2021). It has raised $156 million across 4 recorded rounds; the latest was a $29.9 million early-stage round in Dec 2024.

Last price · $/share
—
Implied valuation
$293.0M
Total raised
$156.5M
Last round
Early Stage VC
Dec 2024

Who backs Mythic Therapeutics?

17 investors
InvestorType
Viking Global InvestorsAsset manager
BoxGroupVenture capital
First Round CapitalOther
Raptor GroupVenture capital
VenrockVenture capital
Foresite CapitalVenture capital
Refactor CapitalVenture capital
Perceptive AdvisorsHedge fund
Lifeforce CapitalVenture capital
Highside Capital ManagementHedge fund
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mythic Therapeutics investors

17 investors are on record for Mythic Therapeutics, including Viking Global Investors, BoxGroup, First Round Capital and Raptor Group. By type, the record holds 6 venture capital firms, 2 hedge funds and 1 asset manager. The early-stage round in Dec 2024 drew 30 investors.

Free account
More of Mythic Therapeutics with a free account
  • ·The complete investor list: 17 names
  • ·Watch Mythic Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Mythic Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View